BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 8524847)

  • 1. Mutagenesis of palmitoylation sites in endothelial nitric oxide synthase identifies a novel motif for dual acylation and subcellular targeting.
    Robinson LJ; Michel T
    Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11776-80. PubMed ID: 8524847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biosynthesis and palmitoylation of endothelial nitric oxide synthase: mutagenesis of palmitoylation sites, cysteines-15 and/or -26, argues against depalmitoylation-induced translocation of the enzyme.
    Liu J; García-Cardeña G; Sessa WC
    Biochemistry; 1995 Sep; 34(38):12333-40. PubMed ID: 7547976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agonist-modulated palmitoylation of endothelial nitric oxide synthase.
    Robinson LJ; Busconi L; Michel T
    J Biol Chem; 1995 Jan; 270(3):995-8. PubMed ID: 7530714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligomerization of endothelial nitric oxide synthase. Evidence for a dominant negative effect of truncation mutants.
    Lee CM; Robinson LJ; Michel T
    J Biol Chem; 1995 Nov; 270(46):27403-6. PubMed ID: 7499193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic regulation of endothelial nitric oxide synthase: complementary roles of dual acylation and caveolin interactions.
    Feron O; Michel JB; Sase K; Michel T
    Biochemistry; 1998 Jan; 37(1):193-200. PubMed ID: 9425039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial nitric oxide synthase membrane targeting. Evidence against involvement of a specific myristate receptor.
    Busconi L; Michel T
    J Biol Chem; 1994 Oct; 269(40):25016-20. PubMed ID: 7523377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A chimeric transmembrane domain directs endothelial nitric-oxide synthase palmitoylation and targeting to plasmalemmal caveolae.
    Prabhakar P; Cheng V; Michel T
    J Biol Chem; 2000 Jun; 275(25):19416-21. PubMed ID: 10787410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel N-terminal motif for palmitoylation of G-protein alpha subunits.
    Parenti M; Viganó MA; Newman CM; Milligan G; Magee AI
    Biochem J; 1993 Apr; 291 ( Pt 2)(Pt 2):349-53. PubMed ID: 8484716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal fatty acylation of the alpha-subunit of the G-protein Gi1: only the myristoylated protein is a substrate for palmitoylation.
    Galbiati F; Guzzi F; Magee AI; Milligan G; Parenti M
    Biochem J; 1994 Nov; 303 ( Pt 3)(Pt 3):697-700. PubMed ID: 7980434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcellular targeting and agonist-induced site-specific phosphorylation of endothelial nitric-oxide synthase.
    Gonzalez E; Kou R; Lin AJ; Golan DE; Michel T
    J Biol Chem; 2002 Oct; 277(42):39554-60. PubMed ID: 12189156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial nitric oxide synthase. N-terminal myristoylation determines subcellular localization.
    Busconi L; Michel T
    J Biol Chem; 1993 Apr; 268(12):8410-3. PubMed ID: 7682550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation of N-myristoylation site converts endothelial cell nitric oxide synthase from a membrane to a cytosolic protein.
    Sessa WC; Barber CM; Lynch KR
    Circ Res; 1993 Apr; 72(4):921-4. PubMed ID: 7680289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting of a G alpha subunit (Gi1 alpha) and c-Src tyrosine kinase to caveolae membranes: clarifying the role of N-myristoylation.
    Song KS; Sargiacomo M; Galbiati F; Parenti M; Lisanti MP
    Cell Mol Biol (Noisy-le-grand); 1997 May; 43(3):293-303. PubMed ID: 9193783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The first 35 amino acids and fatty acylation sites determine the molecular targeting of endothelial nitric oxide synthase into the Golgi region of cells: a green fluorescent protein study.
    Liu J; Hughes TE; Sessa WC
    J Cell Biol; 1997 Jun; 137(7):1525-35. PubMed ID: 9199168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palmitoylation of inducible nitric-oxide synthase at Cys-3 is required for proper intracellular traffic and nitric oxide synthesis.
    Navarro-Lérida I; Corvi MM; Barrientos AA; Gavilanes F; Berthiaume LG; Rodríguez-Crespo I
    J Biol Chem; 2004 Dec; 279(53):55682-9. PubMed ID: 15485846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminally myristoylated Ras proteins require palmitoylation or a polybasic domain for plasma membrane localization.
    Cadwallader KA; Paterson H; Macdonald SG; Hancock JF
    Mol Cell Biol; 1994 Jul; 14(7):4722-30. PubMed ID: 8007974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palmitoylation of endothelial nitric oxide synthase is necessary for optimal stimulated release of nitric oxide: implications for caveolae localization.
    Liu J; García-Cardeña G; Sessa WC
    Biochemistry; 1996 Oct; 35(41):13277-81. PubMed ID: 8873592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant endothelial nitric oxide synthase: post-translational modifications in a baculovirus expression system.
    Busconi L; Michel T
    Mol Pharmacol; 1995 Apr; 47(4):655-9. PubMed ID: 7536885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor regulation of G-protein palmitoylation.
    Mumby SM; Kleuss C; Gilman AG
    Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2800-4. PubMed ID: 8146194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posttranslational modifications of endothelial nitric oxide synthase.
    Robinson LJ; Ghanouni P; Michel T
    Methods Enzymol; 1996; 268():436-48. PubMed ID: 8782610
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.